However, given metformin’s role as a regulator of metabolism, understanding how metformin affects the metabolism of STK11 mutant NSCLC, and whether this process is involved in promoting anti-tumor immunity remains unknown. The gene discussed is STK11; the disease is non-small cell lung carcinoma.